Maxcyte (MXCT)Director sold ~$11K
John Joseph Johnston, Director at Maxcyte, sold ~$11K of Maxcyte shares.
- ~$11K
- Approx. value · 3,000 sh @ $3.72
- 142K
- Holds after · shares reported
- Traded
- Oct 28, 2024
- Filed
- Oct 30, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 1, 2024InsiderDirector sold ~$99K of MXCT shares in the open market
- Oct 2, 2024InsiderDirector sold ~$80K of MXCT shares in the open market
- Oct 28, 2024 · this disclosureInsiderDirector sold ~$11K of MXCT shares in the open market
What came next
- Nov 1, 2024InsiderDirector sold ~$177K of MXCT shares in the open market
- Dec 6, 2024InsiderDirector sold ~$1.9K of MXCT shares in the open market
- Dec 9, 2024InsiderDirector sold ~$9.5K of MXCT shares in the open market
- Dec 26, 2024InsiderDirector sold ~$12K of MXCT shares in the open market
- Jan 13, 2025InsiderOfficer sold ~$20K of MXCT shares in the open market
- Jan 27, 2025InsiderDirector sold ~$14K of MXCT shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Maxcyte
For Maxcyte, OQRO holds 1 federal contract award dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MXCT page.
Other recent filings by John Joseph Johnston, Director
- SEC Form 4 at Maxcyte (MXCT)Jan 29, 2025
- SEC Form 4 at Maxcyte (MXCT)Dec 30, 2024
- SEC Form 4 at Maxcyte (MXCT)Dec 10, 2024
- SEC Form 4 at Maxcyte (MXCT)Dec 10, 2024
The full history of John Joseph Johnston, Director is on the profile page.
How this filing works
Other disclosures at Maxcyte
- USAspending.gov award recordAug 31, 2026
- USAspending.gov award recordMar 25, 2026
- SEC Form 4Aug 27, 2025
- SEC Form 4Aug 13, 2025
- SEC Form 4Aug 13, 2025
- SEC Form 4Aug 13, 2025
Everything OQRO holds on this company is on its MXCT page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
